March 9, 2016
NIAID is seeking applications from small businesses in support of a funding opportunity announcement focusing on moving vaccines and products developed by NIAID intramural scientists into the marketplace. Vaccine and treatment inventions eligible for this award include, but are not limited to: HIV anti-gp120 env vaccine as a therapeutic or HIV prevention vaccine; HPV virus-like particles as a vaccine delivery system and adjuvant; use of the 10E8 broadly neutralizing antibody for HIV treatment and prevention.